Researchers at The Ohio State University College of Medicine and The Ohio State University Wexner Medical Center have been awarded a five-year, $10 million grant from NCI to study the long-term, longitudinal impact of COVID-19 on first responders, health care workers and the general population.
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and The Ohio State University College of Veterinary Medicine have been awarded a five-year, $9.1 million grant Program Project Grant renewal from NCI.
LC-SCRUM-Asia, a cancer genomic screening program, has selected Thermo Fisher Scientific's Ion Torrent Genexus System and Oncomine Precision Assay, a pan-cancer panel, to advance precision medicine in Asia.
As part of a broader health care package, the Trump administration Sept. 24 issued an executive order to preserve health coverage protections for people with pre-existing conditions should the Supreme Court invalidate the Affordable Care Act.
Leonidas C. Platanias spoke with Alexandria Carolan, a reporter with The Cancer Letter:
Pamela Kunz said she left Stanford School of Medicine because of years of gender-related microaggressions and verbal abuse she experienced there.
These harrowing responses to The Cancer Letter's survey on gender bias are best represented with no interpretation or analysis.
This story is part of The Cancer Letter's ongoing coverage of COVID-19's impact on oncology. A full list of our coverage is available here.This year's Cancer Progress Report from the American Association for Cancer Research provides a chilling overview of the impact COVID-19 has had on cancer.
Earlier this year, as doctors observed that patients afflicted with the novel coronavirus were dying from a cytokine release syndrome, some suggested focusing on suppressing production of interleukin-6 to control this immune response gone haywire.
FDA has granted Rhenium NanoLiposomes Fast Track Designation for the treatment of patients with recurrent glioblastoma.
